论文部分内容阅读
企业简介2005年成立武汉兴鼎生物科技有限公司,2008年公司实现重组,并先后于2010年、2011年成立江西兴鼎科技有限公司和石家庄原料药生产基地,2014年2月成立衡水兴鼎生物技术有限公司。目前,公司总投资超过8000万元,总占地220余亩,拥有中部地区最大的兽药GMP生产线和年产5000吨的发酵基地,与国内众多大型饲料集团和养殖场建立了稳定的合作,
Company Profile Established in 2005, Wuhan Xing Ding Biological Technology Co., Ltd., the company reorganization in 2008, and successively established Jiangxi Xing Ding Technology Co., Ltd. and Shijiazhuang API production base in 2010 and 2011. In February 2014, Heng Shing Hing Ding Bio Technology Co., Ltd. At present, the company has a total investment of more than 80 million yuan and a total area of more than 220 acres. It owns the largest veterinary drug GMP production line in the central region and a 5,000-ton fermentation base annually. It has established stable cooperation with many large feed groups and farms in the country,